Adagio Medical Holdings, Inc. — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Todd Usen (CEO) and Deborah Kaster (CFO) certified the June 30, 2026 quarterly report on August 11, 2026, attesting that financial statements fairly present the company's condition and operations, disclosure controls are effective, and no material weaknesses or fraud were identified. These are standard Sarbanes-Oxley Section 302 and 906 certifications required for all public companies.
Why this rating
Boilerplate SOX certification exhibits. No substantive business event, transaction, or operational change disclosed. Routine periodic regulatory filing requirement.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.